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Abstract
Background: Interest in developing physically active pediculicides has identified new active substances. The objective was
to evaluate a new treatment for clinical efficacy.
Methods and Findings: We describe the selection of 1,2-octanediol as a potential pediculicide. Clinical studies were
community based. The main outcome measure was no live lice, after two treatments, with follow up visits over 14
days. Study 1 was a proof of concept with 18/20 (90%) participants cured. Study 2 was a multicentre, parallel, randomised,
observer-blind study (520 participants) that compared 0.5% malathion liquid with 1,2-octanediol lotion (20% alcohol)
applied 2–2.5 hours or 8 hours/overnight. 1,2-octanediol lotion was significantly (p,0.0005) more effective with success for
124/175 (70.9%) RR=1.50 (97.5% CI, 1.22 to 1.85) for 2–2.5 hours, and 153/174 (87.9%) RR=1.86 (97.5% CI, 1.54 to 2.26) for
8 hours/overnight compared with 81/171 (47.4%) for malathion. Study 3, a two centre, parallel, randomised, observer-blind
study (121 participants), compared 1,2-octanediol lotion, 2–2.5 hours with 1,2-octanediol alcohol free mousse applied for 2–
2.5 hours or 8 hours/overnight. The mousse applied for 8 hours/overnight cured 31/40 (77.5%), compared with 24/40
(60.0%) for lotion (RR=1.29, 95% CI, 0.95 to 1.75; NNT=5.7) but mousse applied for 2–2.5 hours 17/41 (41.5%) was less
effective than lotion (RR=0.69, 95% CI, 0.44 to 1.08). Adverse events were more common using 1,2-octanediol lotion at
both 2–2.5 hours (12.0%, p=0.001) and 8 hours/overnight (14.9%, p,0.0005), compared with 0.5% malathion (2.3%).
Similar reactions were more frequent (p,0.045) using lotion compared with mousse.
Conclusions: 1,2-octanediol was found to eliminate head louse infestation. It is believed to disrupt the insect’s cuticular
lipid, resulting in dehydration. The alcohol free mousse is more acceptable exhibiting significantly fewer adverse reactions.
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Introduction
During the 1990s head lice in many countries were found to
have acquired resistance to treatment using insecticides, resulting
in treatment failures, longer term infestations, and repeated cycles
of treatment. Until about 2005 alternative treatment options were
limited and, although physically acting preparations are now
available, insecticides remain in use in many countries.
Currently used physically acting preparations are mostly
siloxanes or lipids with a low surface tension that enables them
to enter and block the louse spiracles resulting in immobilisation of
the insects and disruption of water balance [1]. However, the
respiratory tract is not the only vulnerable point for physically
acting chemical compounds. Lice, like all insects, are coated with
lipid, which has waterproofing and protective functions for the
chitin cuticle. Dissolution of an insect’s lipid coat can also disrupt
its ability to minimise water loss through the cuticle and is likely to
affect the normal functioning of the cuticle in other ways [2,3].
Surface active agents of various kinds are applied to the hair and
scalp, the most common of which are in toiletry shampoos and
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leading to insect death, but none has previously been commer-
cially exploited.
We conducted preclinical screening of a range of alkyl diols,
used as wetting and spreading agents in toiletries, for activity
against human lice. We found 1,2-octanediol (caprylyl glycol) had
the best characteristics of activity, safety, and history of prior
human use. We have evaluated this material in randomised,
controlled, observer blinded clinical trials randomised by individ-
ual, the preferred approach in scientific advice from the competent
authority. First, 1,2-octandiol was compared with 0.5% malathion,
a standard of care treatment widely prescribed in the UK.
Subsequently, an alcohol free version was compared with the
original preparation.
Materials and Methods
Preclinical work
Preclinical screens of candidate active substances were con-
ducted using laboratory reared clothing/body lice (Pediculus
humanus) as test insects. Adult lice were fed during the morning
before testing and allowed to eliminate excess water from the
bloodmeal over a period of approximately 4 hours before
exposure to treatments in a manner described in previous studies
[4]. Later tests conducted using formulated materials were
performed using head lice collected from children screened under
a separate ethical approval from the clinical investigations. Louse
eggs were obtained by providing fecund adult laboratory reared
clothing lice with a close-spaced nylon gauze substrate over a
period of 48 hours.
Test materials were dissolved in 50% propan-2-ol. Lice or louse
eggs were dipped in the test solution for 10 seconds, blotted of
excess fluid, and then incubated overnight under normal
maintenance conditions (30u62u Celsius and 50%615% relative
humidity). The effects of the materials on lice were recorded
without washing but the gauze squares with louse eggs were
washed using a non-medicated, non-conditioning, frequent use
shampoo (Boots Frequent Wash Shampoo) diluted 1:15 with warm
tap water. The eggs were then blotted dry and incubated until all
nymphs from the control batches of eggs had emerged [4].
Clinical investigations
The protocols for the two randomised, controlled trials and
supporting CONSORT checklist are available as supporting
information: see Checklist S1 and Protocol S1 (Study 2) and
Protocol S2 (Study 3).
Participants. We conducted three clinical studies that
recruited participants via local newspaper and radio advertising.
Families responding to advertising were sent a participant
information booklet (PIB) by post. Those who wished to enrol
telephoned the study coordinator to request a home visit, which
usually occurred within 24 hours. Trained investigators used a
standard protocol to examine participants for head lice using a
plastic detection comb (‘‘PDC’’, KSL Consulting, Denmark). If
lice were found, and the participant was eligible, a signed consent
and assent procedure was followed. Other household members
were offered examination and invited to join if eligible.
All enrolled participants provided baseline data on age, gender,
hair characteristics, and previous pediculicide use. The lower age
limit was 4 years in the proof of concept and first controlled study,
there being no upper limit. For the second controlled study the
lower age limit was 6 months, in conformity with the instructions
for use of the product as a medical device. Treatments and
assessments were conducted in the home. No payment was offered
for participation.
Eligibility and inclusion and exclusion criteria were essentially as
in our previous studies [5–7]. All participants were confirmed as
having live lice present at the time of enrolment and had not used
another pediculicide within 2 weeks of commencement. Partici-
pants confirmed they had no known sensitivity to any product
components, were not using medication for asthma, had not been
treated using co-trimoxazole within 4 weeks, and had not
participated in another clinical study within 30 days. Investigators
also checked for secondary infection of the scalp and confirmed
that prospective participants were not pregnant or nursing
mothers.
Ethics. Ethical approval for the proof of concept study
(protocol CTEP01, ISRCTN66611560) was granted by
Hertfordshire 2 Research Ethics Committee (EudraCT 2005-
005512-24). Approval for the first randomised controlled study
(protocol CTEP02, ISRCTN91870666) was granted by Trent
Research Ethics Committee (EudraCT 2007-001872-36), with
locality issue ethical approvals granted by Cambridgeshire 2 REC,
South West Wales REC, and Leeds (West) REC for the three
study sites. Our second randomised controlled study (protocol
CTMK12, ISRCTN28722846) was approved by Leeds West
REC and locality issues by Cambridgeshire 2 REC.
At the first visit, people who wished to participate reported that
they had read the PIB and understood the purpose and
requirements of the study. Parents or guardians provided written
consent for children younger than 16 years, who also gave written
assent witnessed by the parent/guardian.
The studies were conducted in conformity with the principles of
the Declaration of Helsinki, the International Conference on
Harmonisation (ICH) Harmonised Tripartite Guideline for Good
Clinical Practice (GCP), and of European Union Directives 2001/
20/EC and 2005/28/EC.
Study medications. For the proof of concept (Study 1), we
used a lotion containing 5% (w/v) 1,2-octanediol dissolved in 50%
(v/v) propan-2-ol (isopropanol) and water.
Most people found this preparation had a pungent odour and
caused skin irritation (see Adverse Events), so it was replaced for
the first randomised study (Study 2) by 5% (w/v) 1,2-octanediol in
a vehicle of 20% (v/v) propan-2-ol in water with 0.64% sodium
dodecyl sulphate as a co-surfactant (prepared for EctoPharma Ltd,
Selkirk, Scotland) supplied in 100 ml bottles. The comparison
product was 0.5% malathion liquid in 200 ml bottles (Derbac-M
liquid, SSL International, Manchester, UK). Both preparations
were applied drop by drop and massaged into the hair to ensure
full coverage of the hair and scalp.
Even with reduced alcohol (20%) the odour and irritation were
more than desirable so, for the second randomised study (Study 3),
we used an alcohol free lotion containing 5% w/v 1,2-octanediol
in PEG 6 caprylic/capric glycerides and water (Thornton & Ross
Ltd, Huddersfield, UK). The comparison product was the same
5% (w/v) 1,2-octanediol in 20% (v/v) propan-2-ol in water as used
in Study 2. Each of the preparations was supplied in 150 ml finger
pump bottles fitted with a moussing grid to produce a foam for
easier control of the fluid on the hair.
In all three studies the investigators applied sufficient product to
thoroughly moisten the hair and scalp. The treatment was
repeated after one week. Participants were provided with shampoo
and advised when to wash off the treatment. In Study 2 we
provided carers with cards to record the actual time of washing,
which were then sealed in envelopes until after the initial stage of
data processing.
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or overnight. For Study 2 one cohort using 1,2-octanediol lotion
was also treated for 8 hours or overnight (8–12 hours), a second
used the same product for 2 hours (maximum 2.5 hours to allow
some flexibility of timing within the home environment), and the
third group using the 0.5% malathion liquid washed the product
off after an overnight application.
In Study 3, the three treatment groups were 5% 1,2-octanediol
with 20% isopropanol applied for 2–2.5 hours; 5% 1,2-octanediol
alcohol free applied for 2–2.5 hours; and 5% 1,2-octanediol
alcohol free applied for 8 hours or overnight.
Objectives. After Study 1 had confirmed that 1,2-octanediol
lotion was able to eliminate a head louse infestation, Study 2 was
designed with the objective of comparing the efficacy of 5% 1,2-
octanediol lotion and 0.5% malathion liquid with a power
sufficient to detect superiority of activity of either product but
also to identify whether there were any safety issues in relation to
the preparation in use in a wider population.
Study 3 was designed to demonstrate the activity of 1,2-
octanediol to kill head lice in the absence of alcohol.
Outcomes. For all three studies the primary outcome
measure was elimination of head lice using two applications of
treatment 7 days apart. Initial diagnosis was by dry detection
combing, using the ‘‘PDC’’ comb. We followed up participants in
all studies using the same method on days 2, 6, 9, and 14 in Studies
1 and 2, and on days 1, 6, 9, and 14 for Study 3. Combing to
determine the success or otherwise of treatment was performed
systematically over the whole scalp, but was limited to 2–3 strokes
of the comb on each section in order to minimise the intervention
aspect of combing. The combing examination on day 14 was more
extensive to ensure no lice were present. In all studies, ‘‘Cure’’ was
defined as no lice after the second application of treatment, on
days 9 and 14.
As in previous studies [5–7] we used a rigorous algorithm
defining the criteria for reinfestation as a) no adult lice or third
stage nymphs present following the first treatment; and b) no more
than two adult lice or third stage nymphs found by combing on
days 9 and 14. Any participant not fitting into either the cure or
reinfestation after cure criteria was categorised as a treatment
failure.
Sample size. The sample size determination used for the
proof of concept (Study 1) planned to provide an estimate of cure
rate expected in a controlled study and to determine whether 5%
1,2-octanediol was comparable to existing products with a cure
rate of at least 50%. A group size of 20 narrowed the precision of
the anticipated efficacy to within 10%, and gave confidence
(p#0.048) that an observed cure rate of 50% or lower would be
unlikely if the underlying cure rate was 70% or greater.
Study 2 evaluated three treatment arms, two dose regimens of
5% 1,2-octanediol lotion with 20% alcohol, each separately
compared with malathion liquid. Based on previous experience
[7] we anticipated the efficacy of 0.5% malathion liquid at about
35% with an expected efficacy for 1,2-octanediol lotion to exceed
this by at least 25%. Using a one-tailed alpha of 2.5% we
estimated that 126 participants per group would provide 95%
power to detect superiority. However, for poorer outcome, say a
superiority of 20% we estimated that approximately 163 per
group would provide 90% power. Therefore, to allow for early
withdrawals and other non-evaluable cases, the group size was set
at 170 per arm or a minimum of 510 participants over three
investigation sites.
For Study 3 the aim was to confirm that the 5% 1,2-octanediol
alcohol free lotion (octanediol-AF) had efficacy essentially similar
to that of 5% 1,2-octanediol with 20% alcohol (octanediol lotion).
It was not designed as a full equivalence study but the group size of
40 allowed us to be able to identify, with 95% confidence and up
to 90% power, a difference of 35% in the success rate at 14 days
between the treatments in pair wise comparisons.
Randomisation – allocation concealment. For Study 1 the
treatment allocation was open label.
Study 2 was conducted at three, geographically separate, UK
study sites, in Cambridge, Leeds, and Swansea, each of which was
supplied with sets of pre-numbered, anonymised, boxed, treatment
kits in balanced blocks of twelve. Each investigator was issued with
a complete block of treatment kits to be used in number sequence.
Further blocks were issued as required but any unused packs were
not reallocated at the end of the study. Each kit contained enough
bottles to complete the two treatment applications for one
participant (four 100 ml bottles of 5% 1,2-octanediol lotion or
two 200 ml bottles of 0.5% malathion liquid). Treatment was
allocated using the next available numbered kit held by the
investigator and all kits from one block issued before starting a new
block.
Randomisation was by individual so household members could
receive different treatments. Therefore, in order to minimise the
possibility of allocation bias within a family the lowest available
numbered kit was allocated to the youngest participating
household member, the next number to the next higher in age,
and so on, until all participating members were allocated a
treatment. Infested household members who were not eligible or
declined participation were offered 4% dimeticone lotion (Hedrin
4% lotion, Thornton & Ross Ltd, Huddersfield, UK) as a standard
of care treatment to minimise the risk of reinfestation within the
household.
Study 3 was also randomised by individual. In this study a
treatment allocation code was generated using the free online
randomisation service provided at http://www.randomization.
com, in 14 balanced blocks of 9 treatments. Treatment was
determined from instructions contained in the next available
sequentially numbered, sealed, opaque envelope taken from a
block allocated to the investigator.
For both randomised studies, assessors were blinded to
treatment allocation. Different members of the investigation team
were assigned the task of post-treatment assessment from those
applying treatment. Participants were asked not to provide
information that would disclose the treatment used.
Statistical methods. As there was only one treatment group
for the proof of concept study the only analysis was of the
distribution of graded or semi-continuous variables within the
group.
For the two randomised controlled studies, pair-wise compar-
isons were conducted between each of groups. In Study 2
analyses were conducted based on the whole population and also
based on the youngest member of each household group, each
with stratification for study centre, with unstratified analysis also
conducted for each of the study centres. For stratified data the
method of Mantel and Haenszel [8] was used to calculate
relative rates, with the confidence interval estimated by the
method of Greenland and Robins [9]. In both studies, presence/
absence variables comparisons were made using both the Fisher
exact and chi-squared tests. In some analyses a chi-squared result
only was available because the number of cases was too large for
the exact test to be conducted. For continuous or semi-
continuous variables comparisons were made using Kruskal-
Wallis analysis of variance (equivalent to the Mann-Whitney test
for two group comparison).
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Preclinical work
Our investigation of several series of alkyl alcohols, using the
concentration required to kill 50% of the insects (LC50) as the
benchmark, found that vicinal diols exhibited significantly greater
activity against lice than 1,3-diols and other non-vicinal diols,
irrespective of carbon chain length [10]. For example, 1,2-
decanediol was found to be significantly more active than other
diols, triols and mono-ols (Tables 1 and 2).
When comparing vicinal diols it was found that they exhibited
activity over a range of molecular sizes from C4 to C16 but the
most active to kill lice, using a plot of LC50 values, were 1,2-
octanediol, 1,2-decanediol, and 1,2-dodecanediol (Table 1,
Figure 1) [10]. However, because these chemicals exert no
obvious physiological activity, the effects on adult lice are not
immediate and some insects survive long enough to lay eggs
subsequent to treatment, which could be an important factor in
relation to possible reinfestation. Consequently, inhibition of egg
production could determine the usefulness and efficacy of the
active material. Counting the eggs laid by each batch of treated
lice showed that 1,2-octanediol completely inhibited egg laying,
whereas a few of the insects treated using other vicinal diols did lay
some eggs (Table 2, Figure 2) [10]. These eggs were not affected
by the dried film of diol on the substrate and could survive to start
a new infestation. However, when louse eggs were exposed to
solutions of those vicinal diols found to be most active against lice,
and applied in the same manner as to lice, none of the louse eggs
developed to the point of hatching.
Clinical investigations
Participant flow. In summer 2006, we enrolled 22 people
from 12 families in Study 1. Two were non-compliant and washed
off the treatment early, so we enrolled two additional people to
fulfil the protocol requirement for 20 evaluable participants.
In Study 2, we recruited 520 participants from 275 families
through three study centres: 180 in Cambridge, 166 in Leeds, and
174 in Swansea between October 2007 and May 2008. Of these,
175 were randomised to a 2 hour treatment and 174 to the 8 hour
or overnight treatment, both using octanediol lotion, and 171 to
0.5% malathion liquid. Twenty-three participants did not
complete the study: six left following adverse events, 9 dropped
out, and 8 who were lost to follow up (Figure 3). However, most
participants received two applications of treatment with 7 days
between and were assessed on days 2, 6, 9 and 14 after the first
treatment application.
In Study 3 we recruited 121 participants from 59 households,
between October 2010 and March 2011, 97 in Cambridge and 24
in Leeds. Of these 40 were randomised to receive octanediol lotion
for 2–2.5 hours, 41 to the 2–2.5 hour treatment and 40 to the
8 hour/overnight treatment with the octanediol-AF. Five partic-
ipants did not complete the study: two dropped out, two were lost
to follow up, and one received an incorrect second treatment
(Figure 4). In this study participants were also treated twice with 7
days between and assessments were conducted on days 1, 6, 9, and
14.
Baseline data. In the 334 families enrolled in the two
controlled studies, the mean household size was 4.52 and the
number of participants enrolled ranged from 1 to 6 (mean 1.92)
with no differences between groups. There was a non-significant
trend towards larger household sizes and more people per
household enrolled in Study 3 compared with Study 2.
In Study 2, the different groups showed no overall significant
differences in demographic factors such as age, gender, hair
length, hair thickness (density), degree of curl, or whether dry/
greasy, or for intensity of initial infestation. However, some
variations were identified between or within centres, e.g. in Leeds
there was a significant (p=0.019) overall group difference for age
and the proportion of children younger than 10 was significantly
greater in the malathion group compared with 1,2-octanediol
applied for 8–12 hours (p=0.01). Similarly, Swansea enrolled a
high proportion of males with a significant between group
difference for 1,2-octanediol applied for 2 hours compared with
malathion (p=0.01). The baseline characteristics of groups from
the intention to treat population are summarized in Table 3.
Similarly there were no significant differences between groups in
Study 3, the only trend being the difference in average time since
last treatment, which was twice as long in the group treated using
octanediol-AF for 8 hours compared with octanediol-AF for
2 hours (Table 4).
Table 1. Comparison of the LC50 pediculicidal activity of
vicinal and non-vicinal diols.
Compound Diol type
LC50 value
(mmol/l)
Potency index
(%)*
1,2-Butanediol Vicinal .700 Not effective
1,3-Butanediol Non-vicinal .2000 Not effective
1,2-Hexanediol Vicinal .200 6
1,5-Hexanediol Non-vicinal Not calculable Not effective
1,6-Hexanediol Non-vicinal Not calculable Not effective
2,5-Hexanediol Non-vicinal Not calculable Not effective
1,2-Octanediol Vicinal 40 30
1,3-Octanediol Non-vicinal .400 Not effective
1,2-Decanediol Vicinal 12 100
1,3-Decanediol Non-vicinal 40 30
*The potency index compares the observed LC50 value with that of 1,2-
decanediol (=100%).
doi:10.1371/journal.pone.0035419.t001
Table 2. Comparison of the LC50 pediculicidal activity of
vicinal diols with triols and mono-ols.
Compound LC50 value (mmol/l) Potency index (%)*
1,2,3-Hexanetriol Non calculable Not effective
1,2,6-Hexanetriol Non calculable Not effective
2-Ethyl-1-hexanol 300 4
2-Ethyl-1,3-hexanediol 60 20
1-Decanol 35 32
2-Decanol 37 34
4-Decanol 183 6
9-Decene-1-ol 33 36
1,2-Decanediol 12 100
3-Ethyl-1-decanol 62 20
1-Octyl-1,2-decanediol 97 12
3-Ethyl-1,2-decanediol Non calculable Not effective
*The potency index compares the observed LC50 value with that of 1,2-
decanediol (=100%).
doi:10.1371/journal.pone.0035419.t002
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using the outcome ‘‘cure’’ was 18/20 90.0%. Even on the most
pessimistic assessment of success (after allowing for non-
compliance) the true rate could be estimated at 68.4% with 95%
confidence.
In Study 2, we compared participants for presence of live lice on
each of days 2, 6, 9 and 14, with last value carried forward for any
missing data. Day 2 analyses included 514 participants, and the
remaining analyses 516 participants, because four people missed
all assessments and two missed only the assessment at day 2.
In the intention to treat (ITT) population we saw cure, or
reinfestation after cure, in 81/171 (47.4%) of participants treated
with 0.5% malathion compared with 124/175 (70.9%) for 2–
2.5 hours, and 153/174 (87.9%) for 8 hours/overnight treatments
with 1,2-octanediol lotion. The overall relative rate (RR) versus
malathion was 1.50 (97.5% CI, 1.22 to 1.85) (NNT=4.26) for 1,2-
octanediol 2–2.5 hours and 1.86 (97.5% CI, 1.54 to 2.26)
(NNT=4.19) for 1,2-octanediol 8 hours/overnight.
Over the course of the study 119/171 (69.6%) participants
treated with malathion had lice at some stage after treatment
compared with 72/174 (41.4%) people treated with 1,2-octanediol
8 hours/overnight. Similarly, the mean level of infestation on
malathion treated participants (27.9 lice) was greater than on those
treated using 1,2-octanediol for 8 hours/overnight (3.7 lice). The
treatment success rate using malathion was higher in Swansea 34/
59 (57.6%) compared with Cambridge 24/57 (42.1%) and Leeds
23/55 (41.8%), indicating differences in sensitivity to the
insecticide.
At all time points (4 assessment days), and for all endpoints (live
lice, total number of lice removed, numbers of adult males,
numbers of adult females, and numbers of stage 1, stage 2, and
stage 3 nymphs), lice were most frequent for malathion and least
frequent for 1,2-octanediol 8 hours/overnight, with 1,2-octanediol
2–2.5 hours being intermediate. Overall variation between the
groups and the difference between 1,2-octanediol 8 hours/
overnight and malathion was highly significant (,0.0005) in all
major analyses. The difference between 1,2-octanediol 2 hours
and malathion was also significant at p,0.0005 for 17 of the 28
endpoint/day combinations studied. All the day 9 and 14 analyses
were significant at least at p,0.025.
Outcomes for the per-protocol (PP) analyses were essentially
similar to those for the ITT groups. After exclusion of 23 people
who did not complete the study, two non-compliers, and those
who either could not meet the assessment schedule or where the
time of treatment wash off was incorrect or could not be
calculated, 288 participants (74, 1,2-octanediol 2–2.5 hours; 104,
1,2-octanediol 8 hours/overnight; and 110, malathion) were
analysed for the PP groups. Overall the relative rate of cure for
1,2-octanediol 2–2.5 hours (58/74) versus malathion (52/110) was
1.70 (97.5% CI, 1.31 to 2.22) and for 1,2-octanediol 8 hours/
overnight (93/104) was 1.92 (97.5% CI, 1.50 to 2.44) (Table 2).
The comparison of the 275 youngest family members: 84
allocated to 1,2-octanediol 2–2.5 hours, 98 to 1,2-octanediol
8 hours/overnight, and 93 to malathion avoided issues of inter-
correlations between members of the same family but reduced
power. In this cohort no baseline between-group differences were
Figure 1. Effect of diol chain length on the activity against human lice, Pediculus humanus. Activity of vicinal diols was found for molecules
with carbon chains C4–C16. Activity, as shown by concentration required to kill 50% of insects (LC50), increases with chain length from C4 through to
C10 with a reduction of activity through C12 to C16.
doi:10.1371/journal.pone.0035419.g001
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was for the outcome success of the most recent previous treatment,
where the rates were 25.9% for 1,2-octanediol 8 hours/overnight
and 40.3% for malathion. For the youngest member analysis, the
relative success rate of treatments was 1.61 (97.5% CI, 1.16–2.23)
for 1,2-octanediol 2–2.5 hours, 57/84 (67.9%), versus malathion
39/93 (41.9%) (p=0.001); and for 1,2-octanediol 8 hours/
overnight, 87/98 (88.8%), versus malathion the rate was 2.10
(97.5% CI, 1.58–2.79) (p,0.0005).
For Study 3, we conducted similar analyses to those used for
Study 2 with the exception of youngest in family. For the ITT
population, we found cure or reinfestation in 24/40 (60.0%) of
those treated with 1,2-octanediol lotion (with 20% isopropanol) 2–
2.5 hours, 17/41 (41.5%) in the group treated with alcohol free
1,2-octanediol 2–2.5 hours, and 31/40 (77.5%) for alcohol free
1,2-octanediol lotion 8 hours/overnight. In this study, the overall
RR for alcohol free 1,2-octanediol 2–2.5 hours versus 1,2-
octanediol lotion 2–2.5 hours was 0.69 (95% CI, 0.44 to 1.08),
and for alcohol free 1,2-octanediol 8 hours/overnight versus 1,2-
octanediol lotion 2–2.5 hours was 1.29 (95% CI, 0.95 to 1.75),
which showed that leaving the alcohol free formulation on
overnight significantly (p=0.0021) improved the efficacy com-
pared with using it for only 2–2.5 hours. However, there was no
significant difference between 1,2-octanediol lotion (with 20%
isopropanol) 2–2.5 hours and alcohol free 1,2-octanediol 8 hours/
overnight.
In this study 15 people were excluded from the PP analysis: four
early withdrawals and 11 who missed appointments or did not
comply; leaving 34 participants in the alcohol free 1,2-octanediol
2–2.5 hours group, 37 in the 1,2-octandiol alcohol free 8 hours/
overnight group, and 35 people treated using 1,2-octanediol
lotion. The relative cure rates compared with 1,2-octanediol lotion
(23/35) were 0.72 (95% CI, 0.47 to 1.10) for alcohol free 1,2-
octanediol 2–2.5 hours (16/34) and 1.23 (95% CI, 0.93 to 1.64)
for alcohol free 1,2-octanediol 8 hours/overnight (30/37).
Adverse events. In Study 1, adverse events were all
application site events, generally stinging sensations of moderate
severity, which the adverse events monitors concluded were
probably caused by the high level of alcohol in the preparation. In
the comparative studies, treatment related adverse events were
also primarily application site reactions in which participants
experienced some form of short term irritation, variously described
as an itchy and ‘‘hot’’ paraesthesia-like sensation. Such events all
passed within 15–20 minutes.
In Study 2 we recorded 103 adverse events in 68 participants,
with 45 people having one event, 14 having two, six having three
Figure 2. Effect of diol chain length on the percentage of eggs laid by treated lice. The activity of vicinal diols against lice is relatively slow,
taking several hours for the insects to become fully immobilised. During this time some lice remain capable of laying eggs. It was found that all vicinal
diols, with the exception of 1,2-octanediol allowed a proportion of lice to lay eggs subsequent to treatment.
doi:10.1371/journal.pone.0035419.g002
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showed significantly more participants experienced a treatment
related adverse event after using 1,2-octanediol lotion with 20%
alcohol at either 2–2.5 hours (21=12.0%, p=0.001) or 8 hours/
overnight (26=14.9%, p,0.0005), compared with 0.5% malathi-
on liquid (2=2.3%). There were no serious adverse events
associated with treatment. Two serious adverse events (SAEs) were
reported, both in the group receiving 1,2-octanediol applied for 8–
12 hours, in both cases the participants were involved in road
traffic crashes, neither of which was related to study treatment.
In Study 3, a total of 39 adverse events were reported and no
SAEs. Of these 21 events in 18 participants were considered
possibly or probably related to treatment. Fifteen of these (12
participants) were following treatment with the original 1,2-
octanediol lotion with 20% isopropanol. Those receiving alcohol
free 1,2-octanediol mousse for 2–2.5 hours reported 4 events in
the same number of people (p=0.045) and only two participants
(p=0.008) in the alcohol free 1,2-octanediol mousse 8 hours/
overnight group reported one adverse event each. This gave a RR
of 0.2 (95% CI, 0.08 to 0.48) (NNH=23.3) for experiencing any
application site event using the alcohol free formula, irrespective of
application time compared with the lotion containing 20%
alcohol.
Discussion
We have investigated a group of surface active chemicals with
potential to disrupt insect cuticular lipids in treating head louse
infestation. We found that 1,2-octandiol, which is commonly used
in cosmetics and toiletries as a wetting and spreading agent, had
the greatest overall activity. This material was evaluated in three
clinical studies and in one of these was found to exhibit superior
activity to 0.5% malathion. Since conducting these clinical
investigations, further work has been performed to confirm that
the mechanism of action involves disruption of components of the
lipid coating of the louse (see Supporting Information files: Text
file S1, Table S1, Table S2, Figure S1, Figure S2, Figure S3).
Explanation of results
Most liquid preparations registered as Class I medical devices
for elimination of louse infestation claim to obstruct the respiratory
system [1,5–7]. This is highly effective if the whole insect is coated
and the preparation is able to penetrate all spiracular openings.
However, if insufficient treatment is applied to thoroughly coat the
hair and scalp, some lice can survive. This risk of ‘‘under dosing’’ is
potentially even greater for louse eggs as the structure of the
aeropyle openings of the eggshell cap restricts fluid penetration
and blockage of the airway. Consequently, a physically acting
Figure 3. Flowchart of participants through Study 2. CONSORT flowchart of participants through Study 2. There was a large difference in
numbers analysed by intention to treat (ITT) and per-protocol (PP) mainly due to a specific set of protocol violations indicated by (**). These protocol
violations were primarily failure to comply exactly with timing of wash off of treatment or dates of follow up visits.
doi:10.1371/journal.pone.0035419.g003
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system for its activity offers an attractive therapeutic alternative.
In order to exhibit activity against insects, a surface active
material must be able to disrupt the water protective coating of the
insect. Insect cuticular lipids vary from species to species but in
most cases mainly comprise series of n-alkanes, with varying
additional components such as n-alkenes, methylated alkanes, and
secondary alcohols. The molecular size of these lipids mostly
ranges from around 12 to 40 carbons in chain length depending
upon species [2,3,11]. With such a wide range of molecular size it
is unlikely that any single material would dissolve or disrupt the
majority of the components but short chain alkanes could be
readily displaced or dissolved by surfactants of similar molecular
size.
It has long been recognised that some mono-alcohols can kill
lice and it has been shown that activity increases with chain length
over the range 8 to 12 carbons [12]. Longer chain alcohols also
exhibit some activity but this is less simple to identify or quantify as
those with carbon chain lengths of 14 and above can only be
administered as emulsions. It appears from our in vitro investiga-
tions that the addition of a second alcohol moiety increases the
activity of most medium chain alcohols, compared with mono-ols,
and that this is most effective if placed in the 2-position on the
molecule. Moving the second –OH group to the 3-position, as in
non-vicinal diols, reduces activity significantly [10].
Figure 4. Flowchart of participants through Study 3. CONSORT flowchart of participants through Study 3. Although there few proportionately
fewer protocol violations in the study they were essentially similar to those in Study 2: failure to keep appointments with only one participant in this
study washing out the product at the wrong time.
doi:10.1371/journal.pone.0035419.g004
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diols now need to be further evaluated in relation to the
constitution of the cuticular lipid of human lice. In general terms
the explanation is likely to be that the diol solution is able to
emulsify elements of cuticular lipid and compromise the ability of
lice to prevent water loss through the cuticle. This may seem
Table 3. Demographic characteristics of the intention to treat population at baseline (Study 2).
Characteristic Population Octanediol 2 hours Octanediol .8 hours Malathion .12 hours Total
Number of participants All 175 174 171 520
Cambridge 62 61 57 180
Leeds 55 56 55 166
Swansea 58 57 59 174
Age (,10) All 49.1% 53.4% 56.1% 52.9%
Cambridge 40.3% 54.1% 45.6% 46.7%
Leeds 60.0% 50.0%++ 67.3% 59.0%*
Swansea 48.3% 56.1% 55.9% 53.5%
Sex (male) All 24.0% 17.2% 20.5% 20.6%
Cambridge 19.4% 18.0% 28.1% 21.7%
Leeds 14.5% 16.1% 18.2% 16.3%
Swansea 37.9%++ 17.5% 15.3% 23.6%*
Family size (mean) All 4.35 4.33 4.52 4.40
Participants per family (mean) All 1.76 2.06 1.81 1.88
Hair length (below shoulders) All 57.7% 63.8% 55.0% 58.8%
Hair thickness (thick) All 36.0% 35.6% 34.5% 35.4%
Degree of curl (straight) All 60.6% 57.5% 66.7% 61.5%
Hair type (normal) All 84.0% 85.6% 86.6% 85.4%
Infestation (medium or heavy) All 40.6% 45.4% 39.2% 41.7%
Days since last treatment (median) All 55.0 52.0 60.0 56.0
Previous treatment successful All 34.2% 31.2% 40.6% 35.4%
Key:
++Two sided responses for 1,2-octanediol significantly greater (p,0.025) than for 0.5% malathion.
*Significant (p,0.05) variation between groups.
doi:10.1371/journal.pone.0035419.t003
Table 4. Demographic characteristics of the intention to treat population at baseline (Study 3).
Characteristic Population
Octanediol-AF
2 hours
Octanediol-AF
.8 hours
Octanediol lotion
2 hours Total
Number of participants All 41 40 40 121
Cambridge 33 32 32 97
Leeds 8 8 8 24
Age (,10) All 49.1% 53.4% 56.1% 52.9%
Sex (male) All 19.5% 12.5% 27.5% 19.8%
Family size (mean) All 5.50 5.52 5.50 5.51
Participants per family (mean) All 2.44 2.41 2.45 2.44
Hair length (below shoulders) All 46.3% 60.0% 45.0% 50.4%
Hair thickness (thick) All 46.3% 42.5% 60.0% 49.6%
Degree of curl (straight) All 51.2% 45.0% 67.5% 54.6%
Hair type (normal) All 75.6% 80.0% 75.0% 76.9%
Infestation (medium or heavy) All 63.4% 55.0% 60.0% 59.5%
Days since last treatment (median) All 75.9 155.6 108.3 126.0*
Previous treatment successful All 37.5% 32.5% 26.8% 32.2%
Key:
*Significant (p,0.05) variation between groups.
doi:10.1371/journal.pone.0035419.t004
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[1] but, in terms of overall water management, even active
excretion is controlled to some degree by the insect whereas water
loss through a cuticle that is compromised is not only uncontrolled
but may accidentally result in the insect losing water at a rate too
great for it to maintain its water integrity, resulting in rapid onset
of dehydration. In the case of louse eggs, the activity is more
difficult to interpret but, dissolved in the right vehicle, the 1,2-
octanediol could be carried into the structure of the aeropyles to
disrupt the lipid coat protecting the chorionic membrane
surrounding the developing embryo, with resulting dehydration.
This mode of action is unlikely to be affected by resistance.
Comparison with previous studies
Hitherto surface active chemicals have not been investigated for
their specific activity to treat head louse infestation. Consequently,
it is not possible to make a direct comparison between these results
and others. Other physically acting preparations, such as
dimeticone [5,7] and fatty acid esters [6] have produced similar
results overall, and the differences between the efficacy of these
physically acting materials and currently used insecticides were
essentially similar to the results we found when comparing 1,2-
octanediol with malathion. [6,7] Our larger randomised study has
provided not only a substantial body of evidence for the activity of
1,2-octanediol but also has confirmed the relative inefficacy of
0.5% malathion liquid in geographically widely separated sites,
two of which have only previously been investigated using in vitro
bioassays. [7,13,14] Malathion was selected for comparison
because it was still recommended for prescribers by the British
National Formulary at the time, despite evidence of resistance
[13]; although our data from Swansea appear to confirm the
suggestion [14] that prevalence of resistance to the insecticide may
be lower in Wales than in Leeds and Cambridge. Malathion was
also selected because it was, at the time, considered a ‘‘gold
standard’’ in several countries in Western Europe, Australia, and
in North America. No other insecticides were available in the UK
apart from permethrin, which is even more affected by resistance
problems than malathion, because materials such a carbaril and
lindane were not only no longer available but also so little used in
other territories that any results in comparison with them would
have little value for most clinicians.
Advantages of 1,2-octandiol as a pediculicide
Use of alcohols (ethanol or isopropanol) in the solvent vehicle
for pediculicides has a long history, partly because they made
formulation relatively easy and partly because it was believed they
contributed towards the activity of the preparation. The negative
effects of alcohol are flammability and irritation of the application
site, especially on excoriated skin, yet several widely used products
are still based on alcohol in Europe (Prioderm lotion), USA
(Ovide), and Australia (KP24 lotion). In the development of the
1,2-octanediol product, isopropanol was first used for the reasons
stated above but in clinical use it was clearly unsuitable as a vehicle
due to the level of side effects incurred. Unlike conventional
insecticides, which are all hydrophobic, 1,2-octanediol is partially
hydrophilic and mixes into water with a little co-solvent assistance.
We found that the resulting mixture was not quite as effective as
when alcohol was included but this was outweighed by the greater
acceptability and complete lack of flammability.
For all three formulations we have tested it was necessary to
apply the product a second time because not all louse eggs were
killed by the first treatment. Of course, the majority of consumers
would prefer a treatment that required just one application but
even the most effective preparations applied thoroughly can
sometimes fail to kill one or two eggs, mostly through incomplete
coverage. By making the alcohol free 1,2-octanediol product as a
controllable mousse some issues with application technique were
addressed. As with conventional insecticides, we showed that
leaving the product on the hair for longer improved activity.
Leaving 1,2-octanediol on the hair to allow it longer to act is much
safer than doing this with neurotoxic compounds, especially
carbaril, and lindane, and, combined with its relatively unobtru-
sive appearance and lack of odour could make it more acceptable
to both children and their care givers.
Strengths and weaknesses of the studies
Recruitment to these studies, as with all our clinical studies, was
by response to advertising and as a result a group of participants
with infestations that were more difficult to treat by conventional
preparations may have been selected. However, such problems are
only likely to have influenced the outcome of treatment using
conventional insecticide, for example malathion resistance has
been known in Cambridge since 1996 [15] and in Leeds since at
least 2002 [13] and in both localities the intensity of resistance has
increased rather than diminished (IF Burgess and K Kay,
unpublished data). Problems with resistance to malathion would
not, and did not, have any impact on the efficacy of the non-
neuroactive 1,2-octanediol, demonstrating that this type of
physically acting material is useful in treating infestations that
are not responsive to conventional insecticide. In addition, our
investigation method, in which each participant is followed up on
four separate occasions in addition to the treatment days, has the
advantage that it is rigorous in detection of treatment failure,
although this again may result in some selection of participants
who do not wish for this level of intervention in their routine.
Conclusions and practice implications
Our observations of 5% 1,2-octanediol preparations show that it
is an effective and well tolerated pediculicide. Where resistance to
conventional insecticides is a potential problem, and for those
people who dislike the oiliness of some other physically acting
preparations, 1,2-octanediol, which appears to act by the novel
mode of action to disrupt cuticular lipid on both head lice and
their eggs, offers a cure rate of around 80% when applied for
8 hours/overnight on two occasions. When formulated in an
alcohol free preparation this material was better tolerated and
showed only transient side effects in a few participants.
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surface by the fluid.
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Figure S2 GC-MS chromatogram of cuticle lipid extract
from untreated head lice.
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